Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Sunitinib × 30 days × Clear all

Status

Sponsor Class

Study Type

Interventional 8 Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1

Interventions

selinexor 1 mifamurtide 1 futibatinib 1 dodecyl maltoside 1 capmatinib 1 Sunitinib 1 Eflornithine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06948955 2026-03-09

Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

Cogent Biosciences, Inc.

GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡